Earnings Outlook For Xeris Biopharma Holdings

Xeris Biopharma Holdings XERS is set to give its latest quarterly earnings report on Thursday, 2025-05-08. Here's what investors need to know before the announcement.

Analysts estimate that Xeris Biopharma Holdings will report an earnings per share (EPS) of $-0.04.

Investors in Xeris Biopharma Holdings are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.

It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.

Historical Earnings Performance

In the previous earnings release, the company missed EPS by $0.01, leading to a 2.66% increase in the share price the following trading session.

Here's a look at Xeris Biopharma Holdings's past performance and the resulting price change:

Stock Performance

Shares of Xeris Biopharma Holdings were trading at $4.3 as of May 06. Over the last 52-week period, shares are up 140.46%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for Xeris Biopharma Holdings visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.